BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5125058)

  • 1. [Data on the therapeutic action of amantadine in parkinsonian syndromes].
    Barone A; Gentile A; Scoleri G
    Minerva Med; 1971 Oct; 62(82):3979-83. PubMed ID: 5125058
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary results of the use of amantadine in parkinsonian syndromes].
    Montanari M; Monaco V; Robotti CA
    Minerva Med; 1971 Oct; 62(82):3955-7. PubMed ID: 5125050
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
    Ambrosetto C; Martinelli P
    Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of amantadine on parkinsonian tremor].
    Agnoli A; Casacchia M; Ruggieri S; Volante F; Accornero N
    Minerva Med; 1971 Oct; 62(82):3990-3. PubMed ID: 5125061
    [No Abstract]   [Full Text] [Related]  

  • 5. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the palm-chin reflex in parkinsonian patients treated with L-adamantyl-amine hydrochloride (amantadine)].
    Loria G; D'Arrigo G; Di Stefano F
    Riv Neurobiol; 1971; 17(3):379-87. PubMed ID: 5156133
    [No Abstract]   [Full Text] [Related]  

  • 7. [Psychotic reactions in parkinsonian patients treated with amantadine].
    Fernández Martín F
    Rev Clin Esp; 1970 Aug; 118(4):371-2. PubMed ID: 5486104
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A; Nardini M; Sorgona F
    Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245
    [No Abstract]   [Full Text] [Related]  

  • 9. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes].
    Kluzer G; Lampo B
    Minerva Med; 1971 Oct; 62(82):4013-4. PubMed ID: 5125067
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of amantadine sulfate as a infusion solution in the treatment of parkinsonian syndrome].
    Muschard F; Völler GW
    Med Welt; 1973 Feb; 24(5):183-4. PubMed ID: 4617092
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined treatment of parkinsonian syndromes with amantadine and gamma hydroxybutyric acid].
    Ferrari W; Rossini R; Bonasegla F; Boncinelli A; Prandi G; Greggia A
    Minerva Med; 1971 Oct; 62(82):3958-9. PubMed ID: 5125051
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects induced by the treatment with amantadine on habituation of trigemino-facial reflexes in Parkinsonian patients].
    Messina C; Tomasello F
    Riv Neurol; 1972; 42(2):202-8. PubMed ID: 4341955
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental and clinical data on the mechanism of action of amantadine and on its effectiveness in Parkinson's disease].
    Beani L; Bianchi C; Gomirato G; Perfetti C; Cartei M
    Minerva Med; 1971 Oct; 62(82):3948-51. PubMed ID: 5125048
    [No Abstract]   [Full Text] [Related]  

  • 14. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes and their implications for rehabilitation].
    Raspa EG; Paciaroni E; Saccomanno G
    Minerva Med; 1971 Oct; 62(82):4031-5. PubMed ID: 5125073
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic effects of amantadine hydrochloride on manifestations of parkinsonism].
    Espadaler Medina JM; Olivella Rius J; Ruscadella Nadal J
    Rev Esp Otoneurooftalmol Neurocir; 1969-1970; 28(164):236-46. PubMed ID: 5398580
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of the Soviet preparation midantan in the treatment of the Parkinsonian syndrome].
    Balunov OA; Bazhin EF; Morozova ES; Fedotenkova TN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(8):1178-81. PubMed ID: 4417237
    [No Abstract]   [Full Text] [Related]  

  • 17. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
    Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K
    No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic experiences with amantadine sulfate as a monotherapeutic drug in patients with Parkinsonism].
    Völler GW; Deze J
    Z Allgemeinmed; 1973 May; 49(14):664-70. PubMed ID: 4585272
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term effects of amantadine in striatal syndromes].
    Rovetta P
    Minerva Med; 1971 Oct; 62(82):3965-7. PubMed ID: 5125054
    [No Abstract]   [Full Text] [Related]  

  • 20. Amantidine for relief of Parkinsonian tremor.
    Lutz EG
    J Med Soc N J; 1971 Sep; 68(9):747-51. PubMed ID: 5285959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.